Effect of ipratropium bromide in bronchial asthma.

dc.contributor.authorTaskar, Ven_US
dc.contributor.authorMirchandani, Len_US
dc.contributor.authorMahashur, A Aen_US
dc.contributor.authorSharma, R Ren_US
dc.contributor.authorKolhatkar, V Pen_US
dc.date.accessioned1992-07-01en_US
dc.date.accessioned2009-06-02T12:03:16Z
dc.date.available1992-07-01en_US
dc.date.available2009-06-02T12:03:16Z
dc.date.issued1992-07-01en_US
dc.description.abstractThe effect of inhalation of ipratropium bromide was evaluated in 20 patients with bronchial asthma. It was observed that there was no significant improvement in the forced vital capacity and the forced expired volume in one second, while there was significant improvement in the peak expiratory flow rate (PEFR) measured at 9 pm, after inhalation of 2 puffs of ipratropium bromide aerosol (0.02mg/puff) three to four times a day for 2 weeks. Since PEFR is a measure of large airway function and cholinergic mechanisms are primarily involved for airflow obstruction at large airways, improvement in PEFR by ipratropium bromide highlights its role as a useful bronchodilator in patients in whom vagal reflexes are responsible for the provocation of bronchoconstriction.en_US
dc.description.affiliationDept of Respiratory Medicine, KEM Hospital, Parel, Bombay, Maharashtra.en_US
dc.identifier.citationTaskar V, Mirchandani L, Mahashur AA, Sharma RR, Kolhatkar VP. Effect of ipratropium bromide in bronchial asthma. Journal of Postgraduate Medicine. 1992 Jul-Sep; 38(3): 124-6en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/116642
dc.language.isoengen_US
dc.source.urihttps://www.jpgmonline.comen_US
dc.subject.meshAdministration, Inhalationen_US
dc.subject.meshAdolescenten_US
dc.subject.meshAdulten_US
dc.subject.meshAerosolsen_US
dc.subject.meshAsthma --drug therapyen_US
dc.subject.meshDrug Administration Scheduleen_US
dc.subject.meshFemaleen_US
dc.subject.meshForced Expiratory Volume --drug effectsen_US
dc.subject.meshHumansen_US
dc.subject.meshIpratropium --administration & dosageen_US
dc.subject.meshMaleen_US
dc.subject.meshPeak Expiratory Flow Rate --drug effectsen_US
dc.subject.meshTime Factorsen_US
dc.subject.meshVital Capacity --drug effectsen_US
dc.titleEffect of ipratropium bromide in bronchial asthma.en_US
dc.typeJournal Articleen_US
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.79 KB
Format:
Plain Text
Description: